Clinical Trials Directory

Trials / Conditions / High-grade B-cell Lymphoma (HGBCL)

High-grade B-cell Lymphoma (HGBCL)

9 registered clinical trials studyying High-grade B-cell Lymphoma (HGBCL) — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingNexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)
NCT07502118
Health Institutes of TurkeyPhase 2 / Phase 3
RecruitingA Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relap
NCT06703892
GenomeFrontier Therapeutics TW Co., Ltd.Phase 1
RecruitingStudy of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or
NCT06918912
Istituto Clinico HumanitasPhase 2
RecruitingDALY II USA/ MB-CART2019.1 for DLBCL
NCT04792489
Miltenyi Biomedicine GmbHPhase 2
Active Not RecruitingOptimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy
NCT04745559
H. Lee Moffitt Cancer Center and Research InstitutePhase 2
Active Not RecruitingFirst-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037
GenmabPhase 1 / Phase 2
CompletedStudy Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgk
NCT02348216
Kite, A Gilead CompanyPhase 1 / Phase 2
AvailableA Compassionate Use (CU) Program of Odronextamab
NCT05619367
Regeneron Pharmaceuticals—
Approved For MarketingExpanded Access Program for Epcoritamab
NCT05733650
Genmab—